2022
Project title: Yeast cell factory for mRNA bioproduction
Project duration: April 2022 – March 2025
Partners: CNRS, INRAE, UAVR, UBI, TRON gGmbH, EURICE, IBCH PAS, BIASEP
On April 1, 2022, BIA Separations (Sartorius) became part of Yeast cell factory for mRNA production – a research project funded by the European Innovation Council (EIC).
As part of Yscript, our team will collaborate with seven other partners from five countries over the next three years to establish a specific mRNA bioproduction process in yeast in order to develop novel therapeutics for numerous diseases.
The main problem with the only available technology for mRNA production (in vitro transcription – IVT) is the high production cost due to the complex supply chain and expensive purification process. The Yscript consortium aims to create a customized yeast-based messenger RNA platform for large-scale and cost-effective production of mRNA therapeutics. We look forward to contributing our extensive expertise and experience to achieve the project goals.
To learn more about Yscript project, please visit www.yscript.eu.
